Clera home
·Dashboard

TRM Labs

Backed byBlockchain Capital
Total raised$218.2M
StageSeries C
Hiring pace67 roles / 90d
Founded2018
Team size201-500
HQSan Francisco, California
IndustriesAnti-money launderingBlockchain analysisTransaction monitoringCrypto complianceBlockchain forensicsand Sanctions compliance

About TRM Labs

TRM Labs is a blockchain intelligence company dedicated to building a safer financial system for billions of people. The company helps financial institutions, crypto businesses, and government agencies detect and investigate crypto-related financial crime and fraud through its expertise in data engineering, data science, and threat intelligence. By providing critical insights into blockchain activity, TRM Labs enables its clients to identify suspicious transactions and protect themselves against illicit financial activity in the cryptocurrency ecosystem.

Open positions · 69

Company at a glance

Locations
San Francisco, United States ·Los Angeles, United States ·New York City, United States
Websitetrmlabs.com
LinkedInLinkedIn

Founders & Leadership

ER

Emma Rhodes

Executive Operations

LinkedIn
SR

Sujit Raman

Chief Legal Officer @ TRM Labs | former U.S. Associate Deputy Attorney General

LinkedIn
PS

Patrick S.

Chief Revenue Officer @ TRM Labs [We’re Hiring!]

LinkedIn
EC

Esteban Castaño

CEO at TRM Labs - We're hiring!

LinkedIn
RR

Rahul R.

Co-Founder @ TRM Labs (YC S19) | We're hiring!

LinkedIn
+48 more on LinkedIn

Investors

+15 more investors

Location

About the Team

Team Distribution

  • Operations36%
  • Engineering26%
  • Sales & Business Development22%
  • Other Specialized10%
  • No Information3%

Where the Team Studied

  1. 1.University of Southern California
  2. 2.Harvard University
  3. 3.UC Santa Barbara
  4. 4.Georgetown University
  5. 5.University of Virginia

Team Worked At

  • Google
  • Coinbase
  • Chainalysis
  • Goldman Sachs
  • McKinsey & Company

Team Composition

353 people
  • Engineering2 senior81
  • Human Resources2 senior28
  • Sales19 senior26
  • Operations2 senior24
  • Information Technology1 senior19
  • Legal3 senior18
  • Research1 senior17
  • Marketing4 senior13

Funding History

Cumulative Funding
Valuation

Frequently asked questions

Companies similar to TRM Labs

Red Hibbert Group

Building brands, Creating new relationships, Adding value to our clients

Data Infrastructure and Analytics201-500
9 Mothers

9 Mothers Defense develops fast and cost-effective counter-small UAS (C-sUAS). The company uses AI for detection, tracking and defensive systems to protect against aerial threats, building AI-powered machines designed to intercept and neutralize Group 1/sUAS threats in real time. Operating in the defense industry with a focus on immediate threat countermeasures, it pursues mission-critical work countering immediate real-world aerial threats. Meaningful early equity for foundational owners and direct roadmap influence give employees a seat at the table shaping product and technology trajectory from day one, with zero red tape allowing them to make technical decisions autonomously. An on-site team in Austin, Texas builds robots, sensors and models to control them from scratch, using Python and Rust on embedded hardware, and their work spans vision, acoustics, radar and control systems across hardware and software.

Aerospace and Defense
Aira

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

HealthTech1-10